The global cancer biomarkers market is poised for robust growth, projected to expand from USD 26.23 billion in 2024 to an impressive USD 84.43 billion by 2034, reflecting a compound annual growth rate (CAGR) of 12.4% during the forecast period. This significant market expansion is driven by the increasing prevalence of cancer worldwide, the rising demand for early detection tools, and... https://wemarketresearch.com/reports/cancer-biomarkers-market/136